Lipoprotein-bound endotoxin exerts an immunomodulatory effect on hepatocytes through the lipid A domain of LPS

Journal of Endotoxin Research

Volumn 11, Issue 1, 2005, Pages 19-24

  Kasravi, F Behzad ^a   Lee, Diana H ^a   Weisgraber, Karl ^a   Harris, Hobart W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokine tolerance; Lipoproteins; LPS; Rat; Sepsis

Indexed keywords

CHYLOMICRON; CYTOKINE; ENDOTOXIN; LIPID A; LIPOPOLYSACCHARIDE; LIPOPROTEIN; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL STIMULATION; COMPLEX FORMATION; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNOMODULATION; INFLAMMATION; LIPID ANALYSIS; LIVER CELL; LIVER TOXICITY; MACROMOLECULE; MALE; NONHUMAN; PROTEIN DOMAIN; PROTEIN STRUCTURE; RAT;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHYLOMICRONS; CYTOKINES; ENDOTOXINS; HEPATOCYTES; LIPID A; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; NITRIC OXIDE; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 17344368274     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805105225006731     Document Type: Article

References (33)

1. The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987; 317: 659-665.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.
3. Morrison DC, Silverstein R, Luchi M, Shnyra A. Structure-function relationships of bacterial endotoxins. Contribution to microbial sepsis. Infect Dis Clin North Am 1999; 13: 313-340.
4. Kushner I, Mackiewicz A. Acute phase proteins as disease markers. Dis Markers 1987; 5: 1-11.
5. Van Zee KJ, Coyle SM, Calvano SE et al. Influence of IL-1 receptor blockade on the human response to endotoxemia. J Immunol 1995; 154: 1499-1507.
6. Feingold KR, Serio MK, Adi S, Moser AH, Grunfeld C. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology 1989; 124: 2336-2342.
7. Thieblemont N, Wright SD. Transport of bacterial lipopolysaccharide to the Golgi apparatus. J Exp Med 1999; 190 523-534.
8. Harris HW, Grunfeld C, Feingold KR, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990; 86: 696-702.
9. Harris HW, Grunfeld C, Feingold KR et al. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993; 91: 1028-1034.
10. Harris HW, Johnson JA, Wigmore SJ. Endogenous lipoproteins impact the response to endotoxin in humans. Crit Care Med 2002; 30: 23-31.
11. Harris HW, Rockey DC, Chau P Chylomicrons alter the hepatic distribution and cellular response to endotoxin in rats. Hepatology 1998; 27: 1341-1348.
12. Kasravi FB, Welch WJ, Peters-Lideu CA, Weisgraber KH, Harris HW. Induction of cytokine tolerance in rodent hepatocytes by chylomicron-bound LPS is low-density lipoprotein receptor dependent. Shock 2003; 19: 157-162.
13. Harris HW, Gosnell JE, Kumwenda ZL. The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. J Endotoxin Res 2000; 6: 421-430.
14. Alexander C, Rietschel ET. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 2001; 7: 167-202.
15. Bissell DM, Tilles JG. Morphology and function of cells of human embryonic liver in monolayer culture. J Cell Biol 1971; 50 222-231.
16. Knook DL, Sleyster EC. Isolated parenchymal, Kupffer and endothelial rat liver cells characterized by their lysosomal enzyme content. Biochem Biophys Res Commun 1980; 96: 250-257.
17. Sakaguchi K, Koide N, Asano K et al. Promotion of spheroid assembly of adult rat hepatocytes by some factor(s) present in the initial 6-hour conditioned medium of the primary culture. Pathobiology 1991; 59: 351-356.
18. Tong JZ, De Lagausie P, Furlan V, Cresteil T, Bernard O, Alvarez F. Long-term culture of adult rat hepatocyte spheroids. Exp Cell Res 1992; 200: 326-332.
19. Redgrave TG, Maranhao RC. Metabolism of protein-free lipid emulsion models of chylomicrons in rats. Biochim Biophys Acta 1985; 835:104-112.
20. Martins IJ, Vilcheze C, Mortimer BC, Bittman R, Redgrave TG. Sterol side chain length and structure affect the clearance of chylomicron-like lipid emulsions in rats and mice. J Lipid Res 1998; 39: 302-312.
21. Morrow JA, Arnold KS, Weisgraber KH. Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli. Protein Expr Purif 1999; 16: 224-230.
22. Kumwenda ZL, Wong CB, Johnson JA, Gosnell JE, Welch WJ, Harris HW. Chylomicron-bound endotoxin selectively inhibits NF-kappaB activation in rat hepatocytes. Shock 2002; 18: 182-188.
23. 15N]-nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
24. Seydel U, Oikawa M, Fukase K, Kusumoto S, Brandenburg K. Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. Eur J Biochem 2000; 267: 3032-3039.
25. Persing DH, Coler RN, Lacy MJ et al. Taking Toll: lipid A mimetics as adjuvants and immunomodulators. Trends Microbiol 2002; 10: S32-S37.
26. He SY, Deng HW, Li YJ. Monophosphoryl lipid A-induced delayed preconditioning is mediated by calcitonin gene-related peptide. Eur J Pharmacol 2001; 420: 143-149.
27. Ishida H, Irie K, Suganuma T et al. A lipid A analog ONO-4007 induces tolerance to plasma leakage in mice. Inflamm Res 2002; 51: 38-43.
28. Reisser D, Pance A, Jeannin JF. Mechanisms of the antitumoral effect of lipid A. Bioessays 2002; 24: 284-289.
29. Low MG, Huang KS. Phosphatidic acid, lysophosphatidic acid, and lipid A are inhibitors of glycosylphosphatidylinositol-specific phospholipase D. Specific inhibition of a phospholipase by product analogues? J Biol Chem 1993; 268: 8480-8490.
30. Low MG, Stutz P. Inhibition of the plasma glycosylphosphatidylinositol-specific phospholipase D by synthetic analogs of lipid A and phosphatidic acid. Arch Biochem Biophys 1999; 371: 332-339.
31. Kasravi FB, Brecht WJ, Weisgraber KH, Harris HW. Induction of cytokine tolerance requires internalization of chylomicron-bound LPS into hepatocytes. J Surg Res 2003; 115: 303-309.
32. Harris HW, Brady SE, Rapp JH. Hepatic endosomal trafficking of lipoprotein-bound endotoxin in rats. J Surg Res 2002; 106. 188-195.
33. Read TE, Harris HW, Grunfeld C et al. Chylomicrons enhance endotoxin excretion in bile. Infect Immun 1993; 61: 3496-3502.